Consensus Addex Therapeutics Ltd

Equities

ADXN

CH0029850754

Delayed Swiss Exchange Other stock markets 06:29:49 2024-05-07 am EDT			5-day change	1st Jan Change
0.0754 ^CHF	+0.53%		+23.61%	+63.91%

Apr. 30	European Equities Traded in the US as American Depositary Receipts Decline	MT
Apr. 29	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT

Evolution of the average Target Price on Addex Therapeutics Ltd

Price target over the last 5 years

History of analyst recommendation changes

bbb2642e216ebf.baLFAKsXCjM7jPMBxgAbAIWAPMUa603DtQoDKWTbKOk.X_2MY-duTwYJ_Mp0pEhPS7HIVvBJpCWB1mxVYRzsUrsk7Z9rx0Y5XQnGxw~637aacb6ad7d31581e12e09ff3671c4f

Analyst Recommendations on Addex Therapeutics Ltd

HC Wainwright Downgrades Addex Therapeutics to Neutral From Buy	22-06-23	MT
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate	22-06-17	DJ
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate	22-06-17	CI
HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Rating	22-05-31	MT
HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy Rating	22-02-11	MT
ADDEX THERAPEUTICS : HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Price Target	21-04-21	MT
Addex Therapeutics : Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM	18-02-02	GL
Addex Therapeutics : Van Leeuwenhoeck Issues Research Note on Addex Therapeutics	16-06-08	GL

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

0.075 CHF

Average target price

0.16 CHF

Spread / Average Target

+113.33%

High Price Target

0.16 CHF

Spread / Highest target

+113.33%

Low Price Target

0.16 CHF

Spread / Lowest Target

+113.33%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Addex Therapeutics Ltd

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar